-
Symbol
-
BTAI on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Shares Owned
-
1,835,192 shares
-
Security Ownership %
-
8.4%
Millennium Management LLC ownership in BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI)
09 Feb 2026 - Millennium Management LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,835,192 shares of BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI).
This represents 8.4% ownership of the company.
In their previous filing dated 01 Oct 2025, INTEGRATED CORE STRATEGIES (US) LLC had reported owning 1,028,053 shares, indicating an increase of +79%.
.